Gene Study for Leprosy Prognosis
Part of Infections clinical trials.
This study looks at whether a specific gene (Rab 32) affects how leprosy progresses. It may help doctors better predict outcomes for people with leprosy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed positive skin smear test for the bacteria that causes leprosy.
- You cannot be allergic to sulfa drugs (a type of antibiotic).
- You cannot be allergic to clofazimine or rifampin (medications used for leprosy).
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain genes (TGF beta 1) in people with leprosy who are already taking multidrug therapy. It aims to understand how these genes might affect the disease, which could lead to better treatments in the future.
This study looks at new ways to diagnose and treat leprosy. It includes patients with a more serious form of leprosy and the people who live closely with them, to help stop the spread of the disease.
This trial tests a new vaccine (LEP-F1 + GLA-SE) to see if it is safe and helps the body fight leprosy. It is for healthy adults living in areas where leprosy is common.
This Phase 3 study tests whether taking preventive antibiotics after possible contact can stop leprosy from developing. If it works, it could protect people in affected communities from getting leprosy (and possibly related infections).
This study looks at cases of Hansen's disease (leprosy) diagnosed in Costa Rica between 2018 and 2025. It aims to understand how the disease is found, treated, and managed, which may help improve care for future patients.
This study tests a new way to diagnose leprosy by taking a tiny sample from a nerve under the skin using ultrasound guidance. The goal is to see if this method can accurately detect leprosy and help doctors know when treatment is working.
Hear when a new Leprosy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.